Information provision indicators |
|
1 | The percentage of patients with symptomatic osteoarthritis, whose notes contain a record that they have been offered education regarding the natural history, treatment, and self-management of the disease at least once | RAND |
| |
2 | The percentage of patients with osteoarthritis treated with an NSAID, whose notes contain a record that they have been advised of the gastrointestinal and renal risks associated with this drug | RAND |
|
Regular assessment indicators |
|
3 | The percentage of patients treated for symptomatic osteoarthritis, whose notes contain a record that they have been assessed for functional status in the last year | RAND |
| |
4 | The percentage of patients treated for symptomatic osteoarthritis, whose notes contain a record that they have been assessed for degree of pain in the last year | RAND |
| |
5 | The percentage of patients with osteoarthritis regularly treated with an NSAID, whose notes contain a record that they have been asked about gastrointestinal symptoms within the previous 12 months | RAND |
|
Treatment provision indicators |
|
6 | The percentage of patients in whom oral pharmacological therapy was initiated to treat osteoarthritis, whose notes contain a record that they were offered paracetamol first (unless contraindicated) | RAND QIGP |
| |
7 | The percentage of patients with osteoarthritis treated with an NSAID, whose notes contain a record that ibuprofen (or a cox-2 inhibitor) has been considered for first-line treatment (unless contraindicated or intolerant) | NICE QIGP |
| |
8 | The percentage of patients with severe symptomatic osteoarthritis of the knee or hip that has failed to respond to non-pharmacological and pharmacological therapy, whose notes contain a record that they were offered referral to an orthopaedic surgeon to be evaluated for total joint replacement within 6 months unless surgery is contraindicated | RAND |
| |
9 | The percentage of patients in whom oral pharmacological therapy was changed from paracetamol to a different oral agent, whose notes contain a record that they were offered a trial of maximum-dose paracetamol | RAND |
|